Fundraising Fox

Tropic Biosciences

Norwich, GB · Founded 2016 · 162 employees on LinkedIn · 13 known investors

Tropic develops improved varieties of tropical crops using gene editing and gene silencing technologies to enhance yield, disease resistance, and climate resilience. The company serves farmers and global consumers by creating staple crops like bananas and rice that reduce pesticide dependency and environmental impact.

AgTechBiotech

Investors · 13

AgronomicsLondonvia Jim Mellon · inferred
Aliment CapitalLos Angeles · $3M – $5M
Blue Horizon CorporationZurich
Canaan PartnersStamford · $500K – $20M
CarbonAmsterdam · $100K
Emerald Technology Ventures AgZurich · $540K – $5.4M
Five Seasons VenturesParis · $2.2M – $10.8M
Future Planet CapitalLondon
Genoa VenturesSan Francisco
Pontifax AgTechSanta Monica
Presidio VenturesSilicon Valley · $500K – $5M
UK Innovation & Science Seed FundLondon · $127K – $635K
Tekfen VenturesreportedNew York · $1M – $3M

Funding

SEC filings, press & company announcements

$105M disclosed across 1 round · 2026

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 1

by search overlap
Freethink17 shared keywordsThe Solutions Project supports and funds a network of community-based organizations working on climate justice in disinvested communities, backing efforts in renewable energy, clean water, regenerative agriculture, and policy advocacy. It focuses on amplifying frontline voices most affected by climate change and environmental inequality.

Companies competing with Tropic Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Companies House · registry record

View on Companies House ↗
Registered name
TROPIC LTD
Company number
04775744
Status
Active
Company type
Private limited company
Incorporated
23 May 2003
Registered office
25 New Meadow Road, Redditch, B98 8YW
Nature of business (SIC)
96090 — Other service activities n.e.c.
Accounts
last made up to 31 Mar 2025 · next due 31 Dec 2026
Confirmation statement
last made up to 23 May 2026 · next due 6 Jun 2027

Current officers · 1

  • Gary Daly — director, appointed 23 May 2003

Source: Companies House public register · retrieved 3 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

UK AgTech startup Tropic secures €91.3 million to bring gene-edited bananas and climate-resilient crops to market | EU-Startupseu-startups.com · Mar 2026Tropic's €91.3M scales gene-edited bananas that beat Panama disease worldwide — TFNtechfundingnews.com · Mar 2026Tropic Raises $105 Million Series C to Scale Commercial Rollout of Gene-Edited Tropical Crops | Tropictropic.bio · Mar 2026Tropic raises over 28M to transform the agriculture industry | Tropictropic.bio · Jun 2022Tropic Raises $40M in Series B Funding - FinSMEsfinsmes.com · Feb 2022

Frequently asked questions

What does Tropic Biosciences do?
Tropic develops improved varieties of tropical crops using gene editing and gene silencing technologies to enhance yield, disease resistance, and climate resilience. The company serves farmers and global consumers by creating staple crops like bananas and rice that reduce pesticide dependency and environmental impact.
Who are Tropic Biosciences's investors?
Tropic Biosciences's investors include Agronomics, Aliment Capital, Blue Horizon Corporation, Canaan Partners, Carbon, Emerald Technology Ventures Ag, Five Seasons Ventures, Future Planet Capital and 5 more.
How much funding has Tropic Biosciences raised?
Tropic Biosciences has disclosed $105M raised across 1 round.
Where is Tropic Biosciences headquartered?
Tropic Biosciences is headquartered in Norwich, GB.